AML患者靶向治疗时代的抗真菌治疗策略

2022-07-21 网络 网络

AML患者靶向治疗时代的抗真菌治疗策略

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1775769, encodeId=a0e01e757692d, content=<a href='/topic/show?id=19e45556efa' target=_blank style='color:#2F92EE;'>#抗真菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55567, encryptionId=19e45556efa, topicName=抗真菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=596c38798743, createdName=amy0563, createdTime=Sun Aug 28 19:13:23 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353842, encodeId=0123135384240, content=<a href='/topic/show?id=dddce266537' target=_blank style='color:#2F92EE;'>#真菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72665, encryptionId=dddce266537, topicName=真菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jul 23 06:13:23 CST 2022, time=2022-07-23, status=1, ipAttribution=)]
    2022-08-28 amy0563
  2. [GetPortalCommentsPageByObjectIdResponse(id=1775769, encodeId=a0e01e757692d, content=<a href='/topic/show?id=19e45556efa' target=_blank style='color:#2F92EE;'>#抗真菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55567, encryptionId=19e45556efa, topicName=抗真菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=596c38798743, createdName=amy0563, createdTime=Sun Aug 28 19:13:23 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353842, encodeId=0123135384240, content=<a href='/topic/show?id=dddce266537' target=_blank style='color:#2F92EE;'>#真菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72665, encryptionId=dddce266537, topicName=真菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jul 23 06:13:23 CST 2022, time=2022-07-23, status=1, ipAttribution=)]
    2022-07-23 zhaojie88

相关资讯

时间验证经典-维奈克拉最佳剂量探索及经典病例分析

时间验证经典-维奈克拉最佳剂量探索及经典病例分析

如何诊断和治疗NPM1突变的AML

如何诊断和治疗NPM1突变的AML

AML文献速递-6月

1、利用现有靶向治疗方案治疗 AML 的临床获益 2、维奈克拉联合强化疗治疗AML或高危MDS的疗效:一项单中心、单臂、2期队列研究

AML靶向治疗策略的探索和展望

AML靶向治疗策略的探索和展望

学术辩论-体健AML患者的诱导方案,化疗or无化疗?

学术辩论-体健AML患者的诱导方案,化疗or无化疗?